Effect of Paliperidone Palmitate 3-Month Formulation on Goal Attainment and Disability After 52 Weeks’ Treatment in Patients with Clinically Stable Schizophrenia

PURPOSE: This pragmatic clinical study aimed to assess goal attainment among patients with schizophrenia treated with paliperidone palmitate 3-monthly (PP3M) and its relation to their level of disability, and whether patients achieved symptomatic remission at the study endpoint. PATIENTS AND METHODS...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuropsychiatr Dis Treat
Hlavní autoři: Lambert, Martin, Sanchez, Pedro, Bergmans, Paul, Gopal, Srihari, Mathews, Maju, Wooller, Annette, Pungor, Katalin
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7767727/
https://ncbi.nlm.nih.gov/pubmed/33380797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S286654
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky